Ved 3. uge sås et fald i det gennemsnitlige antal moderate til svære hedestigninger i behandlingsgruppen med 0, 5 mg
By Week 3, the decrease in mean number of moderate to severe hot flushes for the 0.5 mg estradiol treatment group was statistically significant (p≤0.001) when compared to the placebo group.